Featured Research

from universities, journals, and other organizations

Promising approach to preventing Alzheimer's

Date:
March 1, 2012
Source:
University of Wisconsin-Madison
Summary:
As scientists struggle to find an effective way to prevent Alzheimer's disease, researchers may have found a new approach to interrupting the process that leads to the devastating disease.

The image shows that the enzymes ATase1 and ATase2 are abundantly present in the brains of Alzheimer’s disease patients. The green color labels the ATases while the blue labels the nuclei. Both neurons and glial cells are shown.
Credit: Image courtesy of University of Wisconsin-Madison

As scientists struggle to find an effective way to prevent Alzheimer's disease, researchers at the University of Wisconsin-Madison may have found a new approach to interrupting the process that leads to the devastating disease.

Building on their knowledge of two enzymes that control an "uber" enzyme critical to the development of the disease, the scientists found that the two enzymes are present in the brains of Alzheimer's patients. And by screening some 15,000 compounds, they discovered two that lower activity of the enzymes in test tubes.

The research, published in the Jan. 20 issue of The Journal of Biological Chemistry, offers hope for a novel approach to preventing Alzheimer's disease (AD).

More than five million people in the United State may have Alzheimer's, a complicated disease that has been a challenge to understand. Many researchers have zeroed in on amyloid, which accumulates in the brains of patients with Alzheimer's, as one of the main culprits.

Amyloid originates from a protein called amyloid precursor protein, or APP. An enzyme called beta-site APP cleaving enzyme, or BACE1, cuts APP to produce amyloid and another small fragment called AICD. Both amyloid and AICD are toxic to nerve cells and have been linked to AD.

The current research, under the direction of Dr. Luigi Puglielli, associate professor of medicine at the UW School of Medicine and Public Health (SMPH), centers generally on BACE1. Elevated levels of this enzyme, which rise normally during aging, may lead to high levels of amyloid.

"The prediction is that if you prevent the up-regulation of BACE1 caused by aging, you could prevent the increased risk of Alzheimer's disease that is also associated with aging," says Puglielli, of the Geriatric Research and Education Center at the William S. Middleton Memorial Veterans Hospital in Madison.

Drugs to block BACE1 could, in theory, prevent the build-up of amyloid and help slow or stop the disease. A handful of companies are devoting resources to finding various ways to block BACE1; the Wisconsin Alumni Research Foundation (WARF) has filed a patent for the compounds Puglielli has discovered to be effective.

In 2007, Puglielli and his colleagues discovered that regulation of BACE1 occurs when it undergoes a molecular process called acetylation, which changes its structure. If BACE1 is acetylated, it can travel through the cell in a series of steps to produce the amyloid precursor. If it isn't acetylated, it takes another path toward degradation.

The SMPH team set out to find what makes the acetylation occur, and in 2009 found that two enzymes -- ATase1 and ATase2 -- are responsible.

In the current paper, the researchers found that both ATase1 and ATase2 are expressed in neurons and glial cells. The enzymes are also up-regulated in the brains of AD patients. The researchers looked for compounds that could shut down ATase1 and ATase2, creating an assay to measure the enzyme levels in test tubes so they could screen about 15,000 compounds. The experiments showed that 186 compounds could do the trick.

The scientists then introduced the compounds into several kinds of cellular systems to see if they could reach ATase1 and ATase2 inside the cells.

"We ended up with two compounds that could affect the enzymes in living cells -- compound 9 and compound 19," Puglielli says.

Analyzing the biochemistry and cell biology of the compounds, the scientists found that they shut down ATase1 and 2, which in turn resulted in less acetylation of BACE1--and therefore less production of the amyloid precursor protein.

The UW scientists are now testing the compounds in an animal model of AD. Preliminary results are encouraging.

"Alzheimer's is a complex disease, but finding compounds that affect BACE1 through these two enzymes gives us hope that we are making progress with a novel approach to preventing the disease," Puglielli says.


Story Source:

The above story is based on materials provided by University of Wisconsin-Madison. Note: Materials may be edited for content and length.


Journal Reference:

  1. Y. Ding, M. H. Ko, M. Pehar, F. Kotch, N. R. Peters, Y. Luo, S. M. Salamat, L. Puglielli. Biochemical inhibition of ATase1 and ATase2 activity reduces BACE1 levels and A generation. Journal of Biological Chemistry, 2012; DOI: 10.1074/jbc.M111.310136

Cite This Page:

University of Wisconsin-Madison. "Promising approach to preventing Alzheimer's." ScienceDaily. ScienceDaily, 1 March 2012. <www.sciencedaily.com/releases/2012/03/120301102712.htm>.
University of Wisconsin-Madison. (2012, March 1). Promising approach to preventing Alzheimer's. ScienceDaily. Retrieved August 20, 2014 from www.sciencedaily.com/releases/2012/03/120301102712.htm
University of Wisconsin-Madison. "Promising approach to preventing Alzheimer's." ScienceDaily. www.sciencedaily.com/releases/2012/03/120301102712.htm (accessed August 20, 2014).

Share This




More Mind & Brain News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Researcher Testing on-Field Concussion Scanners

Researcher Testing on-Field Concussion Scanners

AP (Aug. 19, 2014) Four Texas high school football programs are trying out an experimental system designed to diagnose concussions on the field. The technology is in response to growing concern over head trauma in America's most watched sport. (Aug. 19) Video provided by AP
Powered by NewsLook.com
Kids' Drawings At Age 4 Linked To Intelligence At Age 14

Kids' Drawings At Age 4 Linked To Intelligence At Age 14

Newsy (Aug. 19, 2014) A study by King's College London says there's a link between how well kids draw at age 4 and how intelligent they are later in life. Video provided by Newsy
Powered by NewsLook.com
Mental, Neurological Disabilities Up 21% Among Kids

Mental, Neurological Disabilities Up 21% Among Kids

Newsy (Aug. 18, 2014) New numbers show a decade's worth of changes in the number of kids with disabilities. They suggest mental disabilities are up; physical ones are down. Video provided by Newsy
Powered by NewsLook.com
Fake Weed Wreaks Havoc In New Hampshire

Fake Weed Wreaks Havoc In New Hampshire

Newsy (Aug. 17, 2014) New Hampshire's governor declared a state of emergency after more than 40 overdoses of synthetic marijuana in one week throughout the state. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins